You just read:

Mylan Announces the U.S. Patent and Trademark Appeal Board Institutes Inter Partes Review Proceedings on All Claims Against Sanofi's Lantus® Patents

News provided by

Mylan N.V.

Dec 14, 2017, 06:30 EST